Clinical Trials Directory

Trials / Completed

CompletedNCT04677257

Coronary Physiology Testing in Acute Coronary Syndromes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is an interventional, prospective, multicenter study (5 IRCCS hospitals belonging to the Italian Cardiology Network) in patients with STEMI treated with successful primary PCI to assess the ability of coronary physiology parameters measured soon after recanalization to predict myocardial tissue characterization assessed with cardiac magnetic resonance (CMR) within a week of the acute event. Furthermore, patients will be followed up for a period of 12 months to assess the incidence of major adverse cardiovascular events (death, death from cardiovascular causes, re-infarction, new coronary revascularization interventions, development of heart failure) based on their stratification according to coronary physiology parameters.

Detailed description

In the present study the investigators will enroll consecutive patients with STEMI acute myocardial infarction treated with successful primary PCI, to assess the ability of coronary physiology parameters, i.e. coronary flow reserve (CFR) and index of microvascular resistance (IMR) measured after recanalization to predict myocardial tissue characterization (MVO, MSI, IS, T2-rt, T1-rt and ECV) assessed with contrast CMR within a week of the acute event. Furthermore, the relationship between left ventricular end-diastolic pressure and of coronary physiology parameters will be evaluated.

Conditions

Interventions

TypeNameDescription
PROCEDUREPCI, invasive coronary physiology and CMRPatients with acute STEMI will undergo invasive assessment of coronary physiology (IMR and CFR) following successful primary PCI and CMR within a week of the acute event

Timeline

Start date
2020-11-02
Primary completion
2021-11-30
Completion
2022-12-31
First posted
2020-12-21
Last updated
2023-10-04

Locations

5 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT04677257. Inclusion in this directory is not an endorsement.